Elbert Chin
26Patents
5h-index
61Co-inventors
68Inventor score
Filing activity: Jul 22, 2009 → Nov 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10294234B2 | HIV inhibitor compounds | Chemistry; Metallurgy | 16 | Active |
| US8158631B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 12 | Active |
| US11078208B1 | HIV inhibitor compounds | Chemistry; Metallurgy | 12 | Active |
| US8273773B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 10 | Active |
| US10752636B2 | HIV inhibitor compounds | Chemistry; Metallurgy | 5 | Active |
| US11702404B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 5 | Active |
| US10336762B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 5 | Active |
| US11858918B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 3 | Active |
| US10875866B2 | Pyrrolo[1,2-B]pyridazine derivatives | Emerging Cross-Sectional Technologies | 3 | Active |
| US11046686B2 | Thiadiazole IRAK4 compounds | Emerging Cross-Sectional Technologies | 2 | Active |
| US11535622B2 | Pyrrolo[1,2-b] pyridazine derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US11702414B2 | Thiadiazole IRAK4 inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US12060351B2 | Thiadiazole IRAK4 inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US8067442B2 | Heterocyclic antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US9540345B2 | Antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US12121511B2 | GLP-1R modulating compounds | Chemistry; Metallurgy | 0 | Active |
| US9693997B2 | Antiviral compounds | Chemistry; Metallurgy | 0 | Active |
| US11053250B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12084455B2 | HIV inhibitor compounds | Chemistry; Metallurgy | 0 | Active |
| US10100052B2 | Compounds for the treatment of hepatitis B virus infection | General | 0 | Revoked |
| US12037340B2 | Pentacyclic derivatives as Zika virus inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US9617260B2 | Inhibitors of bruton's tyrosine kinase | Human Necessities | 0 | Active |
| US11052087B2 | Anti-HIV compounds | Chemistry; Metallurgy | 0 | Active |
| US12415808B2 | Pyrrolo[1,2-b]pyridazine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US9896433B2 | Antiviral compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.